January 2005- Volume 1, Issue 1

In this Issue

Global News

Sign o’ the times? Drug discovery companies ramp up investments in China

Sign o’ the times? Drug discovery companies ramp up investments in China

Within a single week, two major players in the drug discovery instrumentation and reagent industry—Thermo Electron and Invitrogen—made moves to capitalize on the ever-strengthening Chinese biotechnology and pharmaceutical markets, further entrenching the

Thermo intros LeadStream

Thermo intros LeadStream

Integrated ADMETox platform aimed at easing preclinical bottleneck and lowering development attrition rates.

Pellini named BioAdvance Entrepreneur-in-Residence

Pellini named BioAdvance Entrepreneur-in-Residence

The Biotechnology Greenhouse of Southeastern Pennsylvania BioAdvance recently announced the selection of Dr. Michael Pellini as the organization’s inaugural Entrepreneur-in-Residence. Part of a $2-billion initiative by the Commonwealth of Pennsylvania to

ViroLogic and ACLARA merge

ViroLogic and ACLARA merge

Company sees ‘explosive’ potential in targeted therapeutics
Agilent Technologies expands genomic microarray platform

Automation & Instrumentation

Optics specialist Bookham focuses on life sciences

Optics specialist Bookham focuses on life sciences

In late 2004, Bookham New Focus introduced the Clarity line of fluorescence filters, developed for use in analytical and diagnostic instruments, including fluorescence microscopy, flow cytometry, DNA sequencing, microarrays, and other fluorescence applica

News Briefs

News Briefs

Automation & Instrumentation News Briefs

Caliper Life Sciences licenses microfluidics patents to Predicant

Caliper Life Sciences licenses microfluidics patents to Predicant

Predicant becomes the first company to gain technology rights as Caliper adopts a more expansive out-licensing strategy for its intellectual property estate

Lab-on-a-chip takes next step

Lab-on-a-chip takes next step

The lab-on-a-chip (LOC) field may be about to hit its stride with the recent introduction of a fully automated system by Agilent Technologies. Designed to replace gel electrophoresis steps, the Agilent 5100 ALP allows researchers to perform thousands of u

PerkinElmer, Procognia team up for high–throughput protein array

PerkinElmer, Procognia team up for high–throughput protein array

Health science heavyweight PerkinElmer and proteomics technology developer Procognia announced in mid-December a co-marketing agreement that combines PE’s Protein Array Workstation and ProScan Array HT with Procognia’s U-c lectin array-based platform to c

Informatics

Tripos acquires Optive Research

Tripos acquires Optive Research

In a move that further broadens its offerings in bioinformatics software, Tripos Inc. closed its acquisition earlier this month for Austin, Texas-based Optive Research, a two-year old technology and software spinout of the University of Texas at Austin.

Accelerator adds venture partners

Accelerator adds venture partners

Funding boosts capital pool by $11.8 million and adds informatics expertise

Amgen Ventures to fund emerging biotech companies

Amgen Ventures to fund emerging biotech companies

With $100 million in its coffers, Amgen Ventures, a corporate venture capital fund initiated by Amgen Inc. in late 2004, will provide monetary assistance for emerging biotechnology companies that work in Amgen’s areas of interest related to human therapeu

Nonlinear Dynamics, GenoLogics team up

Nonlinear Dynamics, GenoLogics team up

After several months of discussions, GenoLogics Life Sciences Software Inc., based here, and Nonlinear Dynamics of Newcastle upon Tyne, England, have entered into a global partnership agreement that will result in an integrated protein informatics softwar

News Briefs

News Briefs

Bioinformatics News Briefs

Research & Development

Ricerca Biosciences expands

Ricerca Biosciences expands

Ricerca Biosciences LLC in December completed a capacity expansion of its in vivo pre-clinical testing capability and was also in the process of a similar expansion in its medicinal chemistry and chemical development services. The additional capacity was

Plexxikon bolsters R&D

Plexxikon bolsters R&D

Success of company’s Scaffold-Based Drug Discovery platform puts it on development fast track

California Dreamin’: Proposition 71 puts stem cell research on fast track

California Dreamin’: Proposition 71 puts stem cell research on fast track

Somewhat lost among the rising cheers of public and private research institutions after the passage of California Proposition 71, a measure that will provide nearly $3 billion in public funding in the state for stem cell research over the next 10 years, w

Novasite gets NIH grant

Novasite gets NIH grant

Novasite Pharmaceuticals Inc. announced it has received a four-year grant valued at nearly $3.4 million for continued development of its proprietary parallel screening technology for G-Protein Coupled Receptors (GPCRs).

News Briefs

News Briefs

Research Technology News Briefs

Genomics & Proteomics

Invitrogen launches Human ProtoArray

Invitrogen launches Human ProtoArray

With more than 1,800 proteins on its surface, the new product marks the debut of high-density protein microarrays

Applied Bio names CSO

Applied Bio names CSO

Chief Scientific Officer leads convergence of technology, science

NIST tackles gene expression QC

NIST tackles gene expression QC

With the recent launch of the multidisciplinary Metrology for Gene Expression Program, the National Institute of Standards and Technology (NIST) is hoping to explore and address the challenges associated with the measurement, validation, and quality contr

Ciphergen sells BioSepra to Pall

Ciphergen sells BioSepra to Pall

Pall Corp. in late 2004 finalized the $32-million purchase of Ciphergen Biosystems Inc.’s process chromatography sorbent business. The acquisition of the BioSepra Process Division fills a crucial “missing link” in Pall’s extensive fluid management offerin

Geron in license deal with Cambrex for distribution of telomeraze-immortalized human cell lines

Geron in license deal with Cambrex for distribution of telomeraze-immortalized human cell lines

Geron Corp. in January announced a worldwide license agreement with Cambrex Bio Science Walkersville Inc. under which the Cambrex subsidiary will develop and distribute cell lines that have been immortalized using Geron’s proprietary telomerase technology

News Briefs

News Briefs

Genomics & Proteomics News Briefs
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

November 2022 Issue Front Cover

Latest Issue  

• Volume 18 • Issue 11 • November 2022

November 2022

November 2022